| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000266895.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.04385242 |
Sensitive |
| ENSG00000266895.1 |
Ponatinib |
Esophageal cancer |
0.020526305 |
Resistant |
| ENSG00000266895.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.039130403 |
Sensitive |
